Drugplain

Capmist DM 15 mg/1

Dextromethorphan Hydrobromide, Guaifenesin and Pseudoephedrine Hydrochloride · TABLET · Capital Pharmaceutical, LLC

No Recall History
Plain English

Capmist DM is a tablet containing dextromethorphan hydrobromide, guaifenesin and pseudoephedrine hydrochloride at 15 mg/1, taken oral. Manufactured by Capital Pharmaceutical, LLC.

Key Facts

Brand Name
Capmist DM
Generic Name
Dextromethorphan Hydrobromide, Guaifenesin and Pseudoephedrine Hydrochloride
NDC Code (Product)
29978-601
Manufacturer
Capital Pharmaceutical, LLC
Strength
15 mg/1
Dosage Form
TABLET
Route
ORAL
Marketing Status
Application #
M012
Drug Class
Expectorant [EPC]
Marketing Start
06/20/2013

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

headache4 reports
anxiety2 reports
gait disturbance2 reports
insomnia2 reports
nausea2 reports
affective disorder1 reports
ageusia1 reports
amnesia1 reports
anosmia1 reports
asthenia1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: cough due to minor throat and bronchial irritation helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes and make coughs more productive nasal congestion reduces swelling of nasal passages

Dosage & Administration

Directions Do not exceed recommended dosage. Adults and children 12 years of age and over: 1 tablet every 4 hours, not to exceed 4 tablets in 24 hours, or as directed by a doctor. Children 6 to under 12 years of age: 1/2 tablet every 4 hours, not to exceed 2 tablets in 24 hours, or as directed by a doctor. Children 2 to under 6 years of age: Consult a doctor.

Warnings

Warnings Do not exceed recommended dosage. Do not use this product if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have a cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis, or emphysema a cough that occurs with too much phlegm (mucus) heart disease high blood pressure thyroid disease diabetes trouble urinating due to enlargement of the prostate gland Stop use and ask a doctor if: nervousness, dizziness, or sleeplessness occur cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache. A persistent cough may be a sign of a serious condition. new symptoms occur If pregnant or breast feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Frequently Asked Questions

What is Capmist DM used for?

Capmist DM contains Dextromethorphan Hydrobromide, Guaifenesin and Pseudoephedrine Hydrochloride. It is a tablet taken oral. Consult your doctor for specific uses.

Is Capmist DM a controlled substance?

Capmist DM is not classified as a controlled substance by the DEA.

What is the generic name for Capmist DM?

The generic name for Capmist DM is Dextromethorphan Hydrobromide, Guaifenesin and Pseudoephedrine Hydrochloride. There are no other listed brand versions of Dextromethorphan Hydrobromide, Guaifenesin and Pseudoephedrine Hydrochloride.

What is the NDC code for Capmist DM 15 mg/1?

The NDC (National Drug Code) for Capmist DM 15 mg/1 is 29978-601, listed by Capital Pharmaceutical, LLC.

Product NDC

29978-601

Package NDC

29978-601-30

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)